JAMA study adds new data to decades-long guidance
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Additional analyses of the two trials presented at 2023 ESC Congress
An abundance of promising studies are on the horizon
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Gains are associated with clinical and biomarker benefits in obstructive HCM
Latest results confirm and build on 16-week findings
Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
Why we favor a tailored approach to relieve LVOT obstruction
VADs remain underutilized in non-dilated cardiomyopathy patients
New and ongoing studies aim to reduce the need for surgery, improve risk stratification